BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31647290)

  • 1. Bone Metabolism Parameters in Hemodialysis Patients With Chronic Kidney Disease and in Patients After Kidney Transplantation.
    Marchelek-Myśliwiec M; Dziedziejko V; Nowosiad-Magda M; Wiśniewska M; Safranow K; Pawlik A; Domański L; Dołęgowska K; Dołęgowska B; Stępniewska J; Ciechanowski K
    Physiol Res; 2019 Dec; 68(6):947-954. PubMed ID: 31647290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Plasma Concentration of Klotho Protein, Osteocalcin, Leptin, Adiponectin, and Bone Mineral Density in Patients with Chronic Kidney Disease.
    Marchelek-Mysliwiec M; Wisniewska M; Nowosiad-Magda M; Safranow K; Kwiatkowska E; Banach B; Dołegowska B; Dołegowska K; Stepniewska J; Domanski L; Pawlik A; Ciechanowski K
    Horm Metab Res; 2018 Nov; 50(11):816-821. PubMed ID: 30396210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
    Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis.
    Ahmadi F; Salari S; Maziar S; Esfahanian F; Khazaeipour Z; Ranjbarnovin N
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hemodialysis is associated with lower trabecular bone score, independent of bone mineral density: a case-control study.
    Dusceac R; Niculescu DA; Dobre R; Dragne MC; Tacu C; Peride I; David C; Checherita I; Poiana C
    Arch Osteoporos; 2018 Nov; 13(1):125. PubMed ID: 30426286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
    Sawires HK; Essam RM; Morgan MF; Mahmoud RA
    Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy.
    Liao SC; Moi SH; Chou FF; Yang CH; Chen JB
    Biomed Res Int; 2016; 2016():6453803. PubMed ID: 27999806
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition, adipokines, FGF23-Klotho and bone in kidney transplantation: Is there a link?
    Matei A; Bilha SC; Constantinescu D; Pavel-Tanasa M; Cianga P; Covic A; Branisteanu DD
    J Nephrol; 2022 Jan; 35(1):293-304. PubMed ID: 33560479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.
    Yavropoulou MP; Vaios V; Pikilidou M; Chryssogonidis I; Sachinidou M; Tournis S; Makris K; Kotsa K; Daniilidis M; Haritanti A; Liakopoulos V
    J Clin Densitom; 2017; 20(4):490-497. PubMed ID: 28039046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients.
    Demir C; Dursun AD; Sarıyıldız GT; Arslan Aİ
    Int Urol Nephrol; 2023 Jul; 55(7):1821-1828. PubMed ID: 36773217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin, adiponectin and ghrelin concentrations in post-menopausal women: Is there an association with bone mineral density?
    Mpalaris V; Anagnostis P; Anastasilakis AD; Goulis DG; Doumas A; Iakovou I
    Maturitas; 2016 Jun; 88():32-6. PubMed ID: 27105694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial.
    Mercadal L; Tezenas du Montcel S; Chonchol MB; Debure A; Depreneuf H; Servais A; Bassilios N; Assogba U; Allouache M; Prié D
    Am J Nephrol; 2018; 48(5):349-356. PubMed ID: 30408788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.